Effectiveness of Chloral Hydrate on Brain MRI in Children with Developmental Delay/Intellectual Disability Comparing with Normal Intelligence: Single Tertiary Center Experience

Neurodiagnostic investigation requirements are expanding for diagnostic and therapeutic purposes in children, especially in those with developmental delay/intellectual disability (DD/ID). Thus, determination of optimal sedatives to achieve successful sedation and immobility without further neurologi...

Full description

Saved in:
Bibliographic Details
Main Authors: Ja Un Moon (Author), Ji Yoon Han (Author)
Format: Book
Published: MDPI AG, 2021-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_be9b38e14c47477c9bc48b23f1ed8736
042 |a dc 
100 1 0 |a Ja Un Moon  |e author 
700 1 0 |a Ji Yoon Han  |e author 
245 0 0 |a Effectiveness of Chloral Hydrate on Brain MRI in Children with Developmental Delay/Intellectual Disability Comparing with Normal Intelligence: Single Tertiary Center Experience 
260 |b MDPI AG,   |c 2021-11-01T00:00:00Z. 
500 |a 10.3390/children8121097 
500 |a 2227-9067 
520 |a Neurodiagnostic investigation requirements are expanding for diagnostic and therapeutic purposes in children, especially in those with developmental delay/intellectual disability (DD/ID). Thus, determination of optimal sedatives to achieve successful sedation and immobility without further neurological compromise is important in children with DD/ID. The purpose of this study is to assess the effectiveness and adverse reactions of chloral hydrate (CH) for brain magnetic resonance imaging (B-MRI) in children with DD/ID compared to those with normal intelligence (NI). We performed a retrospective chart review of children aged from 1 day to 12 years who required elective sedation using CH for B-MRI. About 730 cases (415 with DD/ID and 315 with NI) of CH sedation were conducted for B-MRI. Children with DD/ID showed a higher failure rate (22%) than did those with NI (6%); additional CH and prolonged sedation time were required. There was no difference in incidence of adverse reactions between DD/ID and NI groups (<i>p</i> = 0.338). Older or heavier children with DD/ID (<i>p</i> = 0.036 and <i>p</i> = 0.013, respectively), as well as those diagnosed with epilepsy or neuropsychiatric disorders showed higher risk of sedation failure (<i>p</i> < 0.001 for each). In conclusion, CH was a suboptimal sedative drug for children with DD/ID compared with those with NI. Other alternative or supplementary sedatives should be taken into consideration especially for those vulnerable groups. 
546 |a EN 
690 |a chloral hydrate 
690 |a developmental delay 
690 |a intellectual disability 
690 |a sedative 
690 |a children 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n Children, Vol 8, Iss 12, p 1097 (2021) 
787 0 |n https://www.mdpi.com/2227-9067/8/12/1097 
787 0 |n https://doaj.org/toc/2227-9067 
856 4 1 |u https://doaj.org/article/be9b38e14c47477c9bc48b23f1ed8736  |z Connect to this object online.